Dopamine receptors--physiological understanding to therapeutic intervention potential.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Pharmacology and Therapeutics

• Publication date

  1999-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0163-7258(99)00029-7PMID 10596903
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine and depression

  2005cited by this paper
• Pharmacologic properties of (−)-3PPP (preclamol) in man

  2005cited by this paper
• Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390

  2004cited by this paper
• Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach

  1998cited by this paper
• Dose response and concentration response relationship of apomorphine in patients with Parkinson's disease and end-of-dose akinesia.

  1998cited by this paper
• Homologies and differences in the action of drugs of abuse and a conventional reinforcer (food) on dopamine transmission: an interpretative framework of the mechanism of drug dependence.

  1998cited by this paper
• Norepinephrine plus low-dose dopamine: a beneficial combination.

  1998cited by this paper
• Expression and characterization of a dopamine D4R variant associated with delusional disorder

  1998cited by this paper
• The physiological role of dopamine D2 receptors.

  1998cited by this paper
• Human novelty-seeking personality traits and dopamine D4 receptor polymorphisms: a twin and genetic association study.

  1998cited by this paper
• Dopamine function in the prefrontal cortex.

  1998cited by this paper
• A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease.

  1998cited by this paper
• Parkinson's disease. Second of two parts.

  1998cited by this paper
• Dopamine depresses minute ventilation in patients with heart failure.

  1998cited by this paper
• "Renal dose" dopamine in surgical patients: dogma or science?

  1998cited by this paper
• Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension.

  1998cited by this paper
• Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers.

  1998cited by this paper
• Recent biochemical studies of the dopamine transporter--a CNS drug target.

  1998cited by this paper
• The Use of Dopamine and Norepinephrine in the ICU

  1998cited by this paper
• Prominence of the dopamine D2 short isoform in dopaminergic pathways.

  1998cited by this paper
• Effect of YM435, a novel dopamine DA1 receptor agonist, in a canine model of acute congestive heart failure.

  1998cited by this paper
• Drugs of abuse and dopamine cell activity.

  1998cited by this paper
• No association between novelty seeking and the type 4 dopamine receptor gene (DRD4) in two New Zealand samples.

  1998cited by this paper
• Measuring dopamine transporter occupancy by cocaine in vivo: Radiotracer considerations

  1998cited by this paper
• Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.

  1998cited by this paper
• Effects of dopamine agonists and antagonists on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test

  1998cited by this paper
• Pharmacology of Pramipexole, a Dopamine D3-Preferring Agonist Useful in Treating Parkinson's Disease

  1998cited by this paper
• Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia.

  1998cited by this paper
• Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients.

  1998cited by this paper
• The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response

  1998cited by this paper
• Dopamine receptor subtypes as targets for the pharmacotherapy of Parkinson's disease.

  1998cited by this paper
• The cerebral cortex: a case for a common site of action of antipsychotics.

  1998cited by this paper
• Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease.

  1998cited by this paper
• Relationship between subjective effects of cocaine and dopamine transporter occupancy

  1997cited by this paper
• Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.

  1997cited by this paper
• Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist.

  1997cited by this paper
• Polymorphism of dopamine receptors and transporter genes in neuropsychiatric diseases.

  1997cited by this paper
• Dopamine agonists in heart failure: an untimely death.

  1997cited by this paper
• Inhibition of COMT induces dopamine-dependent natriuresis and inhibition of proximal tubular Na+,K+-ATPase.

  1997cited by this paper
• Photoaffinity labeling of D1 and D5 dopamine receptors.

  1997cited by this paper
• Dopamine D2 receptors in signal transduction and behavior.

  1997cited by this paper
• Treating chronic heart failure: time to take stock.

  1997cited by this paper
• Neuroleptic malignant syndrome in parkinsonian patients: risk factors.

  1997cited by this paper
• Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptor.

  1997cited by this paper
• Improved therapies for Parkinson's disease: life beyond dopamine D2/D3 receptor agonists.

  1997cited by this paper
• "Renal" dopamine.

  1997cited by this paper
• Dopamine agonist treatment of tourette disorder in children: Results of an open‐label trial of pergolide

  1997cited by this paper
• Clinical and psychometric correlates of dopamine D2 binding in depression

  1997cited by this paper
• Dopamine hypersensitivity in migraine: role of the apomorphine test.

  1997cited by this paper
• Steady‐State Pharmacokinetic Properties of Pramipexole in Healthy Volunteers

  1997cited by this paper
• A nested case-control study on mortality in users of ibopamine.

  1997cited by this paper
• Differential Autoreceptor Control of Somatodendritic and Axon Terminal Dopamine Release in Substantia Nigra, Ventral Tegmental Area, and Striatum

  1997cited by this paper
• Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice.

  1997cited by this paper
• Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia

  1997cited by this paper
• Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals.

  1997cited by this paper
• Dopamine D1A receptors and renin release in rat juxtaglomerular cells.

  1997cited by this paper
• Cardiovascular Actions of the Dopamine Receptor Agonist Z1046 in Swine

  1997cited by this paper
• Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure

  1996cited by this paper
• Locomotor sensitization to [D-Trp(11)]neurotensin after repeated injections of the dopamine uptake inhibitor GBR12783 in rats.

  1996cited by this paper
• Lack of specific renal haemodynamic effects of different doses of dopamine after infrarenal aortic surgery.

  1996cited by this paper
• Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.

  1996cited by this paper
• Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking

  1996cited by this paper
• Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

  1996cited by this paper
• Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension.

  1996cited by this paper
• Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease.

  1996cited by this paper
• Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease

  1996cited by this paper
• D2L, D2S, and D3 dopamine receptors stably transfected into NG108‐15 cells couple to a voltage‐dependent potassium current via distinct G protein mechanisms

  1996cited by this paper
• Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists.

  1996cited by this paper
• "Renal-dose" dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials.

  1996cited by this paper
• Adaptive Increase in D3 Dopamine Receptors in the Brain Reward Circuits of Human Cocaine Fatalities

  1996cited by this paper
• Migraine Without Aura and Migraine with Aura Are Distinct Clinical Entities: A Study of Four Hundred and Eighty-Four Male and Female Migraineurs From the General Population

  1996cited by this paper
• Highly potent cocaine analogs cause long-lasting increases in locomotor activity.

  1996cited by this paper
• Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.

  1996cited by this paper
• Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking

  1996cited by this paper
• Fetal nigral transplantation as a therapy for Parkinson's disease.

  1996cited by this paper
• Expression of the subtype 1A dopamine receptor in the rat heart.

  1996cited by this paper
• Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group.

  1996cited by this paper
• Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline

  1996cited by this paper
• The effect of deprenyl and levodopa on the progression of Parkinson's disease

  1995cited by this paper
• Full-length cDNA cloning and distribution of human dopamine D4 receptor.

  1995cited by this paper
• Nigral and extranigral pathology in Parkinson's disease.

  1995cited by this paper
• Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache.

  1995cited by this paper
• A simple model to explain the motor fluctuations seen in Parkinson's disease.

  1995cited by this paper
• Cardiovascular, renal, and endocrine actions of dopamine in neonates and children.

  1995cited by this paper
• Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease

  1995cited by this paper
• Effects of putative dopamine D3 receptor agonists, 7-OH-DPAT, and quinpirole, on yawning, stereotypy, and body temperature in rats.

  1995cited by this paper
• D2-Family receptor distribution in human postmortem tissue: an autoradiographic study

  1995cited by this paper
• Pramipexole in patients with early Parkinson's disease.

  1995cited by this paper
• A new approach to emergency department therapy of migraine headache with intravenous haloperidol: a case series.

  1995cited by this paper
• Dopamine agonists in Parkinson's disease

  1995cited by this paper
• Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.

  1995cited by this paper
• Association study between the dopamine D4 receptor gene and schizophrenia.

  1995cited by this paper
• The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease.

  1995cited by this paper
• Behavioural effects of the dopamine D3 receptor agonist 7-OH-DPAT in rats.

  1995cited by this paper
• Dopamine Hypersensitivity in Migraine: Role in Apomorphine Syncope

  1995cited by this paper
• Transcranial Doppler Ultrasound in Migraine and Tension-Type Headache After Apomorphine Administration: Double-Blind Crossover Versus Placebo Study

  1995cited by this paper
• Novel therapeutic directions for Parkinson's disease.

  1995cited by this paper
• Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache.

  1995cited by this paper
• Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man

  1995cited by this paper
• Animal models of mania.

  1995cited by this paper

• Catecholaminergic storm and extreme blood pressure lability induced by combined levodopa/benserazide, selegiline, and piribedil in Parkinson’s disease: a case report

  2026cites this paper
• Plants vs. GPCRs: A workflow for ligand discovery from an extract library illustrated by dopamine receptors.

  2026cites this paper
• Pramipexole improves depression-like behavior in diabetes mellitus with depression rats by inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing impaired neuroplasticity.

  2024cites this paper
• The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons.

  2024cites this paper
• Regulation of neuronal circHomer1 biogenesis by PKA/CREB/ERK-mediated pathways and effects of glutamate and dopamine receptor blockade

  2024cites this paper
• Further exploration of N-4 substituents on the piperazine ring of the hybrid template 5/ 7-{[2-(4-Aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol and its analog: development of an exceptionally potent agonist for D2 & D3 receptors

  2024cites this paper
• Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson’s Disease

  2024cites this paper
• Bivalent dopamine agonists with co-operative binding and functional activities at dopamine D2 receptors, modulate aggregation and toxicity of alpha synuclein protein.

  2022cites this paper
• Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors

  2022cites this paper
• Zebrafish as a potential non-traditional model organism in translational bipolar disorder research: genetic and behavioral insights.

  2022cites this paper
• Dopamine receptor 3: A mystery at the heart of cardiac fibrosis.

  2022cites this paper
• Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats

  2021cites this paper
• Effect of levodopa/carbidopa on stress response in zebrafish

  2021cites this paper
• Impact of hypoxia-ischaemia and dopamine treatment on dopamine receptor binding density in the preterm fetal sheep brain.

  2020cites this paper
• The activities of drug inactive ingredients on biological targets

  2020cites this paper
• Markedly increased prevalence of migraine headaches in adolescents with bipolar disorder

  2020cites this paper
• Re-examining the role of ventral tegmental area dopaminergic neurons in motor activity and reinforcement by chemogenetic and optogenetic manipulation in mice

  2019cites this paper
• Study of complexation of dopamine analogues with bioactive metals by cyclic voltammetry

  2019cites this paper
• Unravelling the D 1 RD 2 R heteromer

  2019cites this paper
• Attention-Deficit and Hyperactivity Disorder: A Disorder or a Fraud?

  2019cites this paper
• Mapping of the prenatal and postnatal methamphetamine effects on D1-like dopamine, M1 and M2 muscarinic receptors in rat central nervous system.

  2018cites this paper
• 6‐n‐propylthiouracil taste disruption and TAS2R38 nontasting form in Parkinson's disease

  2018cites this paper
• Comorbidity of migraine with ADHD in adults

  2018cites this paper
• Migraine and associated comorbidities are three times more frequent in children with ADHD and their mothers.

  2018cites this paper
• Dopamine receptor expression on primary osteoblasts and bone marrow mesenchymal stem cells of rats

  2018cites this paper
• Central hemodynamics and arterial stiffness in idiopathic and multiple system atrophy

  2017cites this paper
• Synthesis and Characterization of new Azecine-Derivatives as Potential Neuroleptics

  2017influential citation
• Association of the DRD2 CAn-STR and DRD3 Ser9Gly polymorphisms with Parkinson's disease and response to dopamine agonists.

  2017cites this paper
• α-Methyltyrosine, a tyrosine hydroxylase inhibitor, decreases stress response in zebrafish (Danio rerio).

  2017cites this paper
• Computer-aided Drug Design Applied to Parkinson Targets

  2017cites this paper
• Considerations for ADHD in the child with epilepsy and the child with migraine

  2017cites this paper
• Cardiovascular Models: Heart Secondarily Affected by Disease (Diabetes Mellitus, Renal Failure, Dysfunctional Sympathetic Innervation)

  2017cites this paper
• Long-Term Efficacy of Pharmacological Treatment

  2017cites this paper
• Dose-Dependent Effect of Dopamine on Rats Myocardium Contractility in Postnatal Ontogenesis

  2016cites this paper
• Investigating susceptibility to bipolar disorder, migraine and epilepsy

  2016cites this paper
• Bipolar disorder related functional variants in the calcium channel gene family

  2016cites this paper
• EFFECTS OF REPEATED ARIPIPRAZOLE TREATMENT ON THE cAMP AND AKT PATHWAYS IN THE DORSAL STRIATUM OF PREADOLESCENT AND ADULT RATS

  2016cites this paper
• Characterization of the dopamine receptor genes in salmon louse, Lepeophtheirus Salmonis

  2016cites this paper
• Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases

  2016cites this paper
• Spectrofluorimetric determination of dopamine receptor antagonist LE 300 in mice plasma.

  2016cites this paper
• Interaction of prenatal stress and morphine alters prolactin and seizure in rat pups.

  2015cites this paper
• Dopamine D3 agonists in the treatment of Parkinson's disease.

  2015cites this paper
• Effects of ovarian dopaminergic receptors on ovulation

  2015cites this paper
• Targets Associated with Drug‐Related Suicidal Ideation and Behavior

  2015cites this paper
• Selective Analysis of Dopamine Receptor Antagonist LE300 and its N-Methyl Metabolite in Mouse Sera at the Trace Level by HPLC–Fluorescence Detection

  2015cites this paper
• Headache and ADHD in Pediatric Age: Possible Physiopathological Links

  2015cites this paper
• Melatonin Inhibits Manganese-Induced Motor Dysfunction and Neuronal Loss in Mice: Involvement of Oxidative Stress and Dopaminergic Neurodegeneration

  2015cites this paper
• Analysis of a second Drosophila Cornichon Protein

  2014cites this paper
• Understanding the Structural Requirements of Hybrid (S)-6-((2-(4-Phenylpiperazin-1-yl)ethyl)(propyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol and its Analogs as D2/D3 Receptor Ligands: A Three-Dimensional Quantitative Structure-Activity Relationship (3D QSAR) Investigation.

  2014cites this paper
• Preterm lambs given intravenous dopamine show increased dopamine in their cerebrospinal fluid

  2014cites this paper
• Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients

  2014influential citation
• Characterization of [3H]LS‐3‐134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand

  2014cites this paper
• Droxidopa for the treatment of neurogenic orthostatic hypotension and other symptoms of neurodegenerative disorders

  2014cites this paper
• Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences.

  2014cites this paper
• Genética de la esquizofrenia: avances en el estudio de genes candidatos

  2014cites this paper
• POLIMORFIZM KATECHOLO-O-METYLOTRANSFERAZY (COMT) ORAZ RECEPTORÓW DOPAMINY (DRD1, DRD4) W ETIOLOGII I TERAPII STANU PRZEDRZUCAWKOWEGO

  2014cites this paper
• Involvement of Dopamine D2 Receptors in Addictive-Like Behaviour for Acetaldehyde

  2014cites this paper
• Pharmacogenetic activation of midbrain dopaminergic neurons induces hyperactivity

  2013cites this paper
• Motivational properties of D2 and D3 dopamine receptors agonists and cocaine, but not with D1 dopamine receptors agonist and L-dopa, in bilateral 6-OHDA-lesioned rat.

  2013cites this paper
• Pharmacological evidence that dopamine inhibits the cardioaccelerator sympathetic outflow via D2-like receptors in pithed rats.

  2013cites this paper
• Parasitic fungus Claviceps as a source for biotechnological production of ergot alkaloids.

  2013cites this paper
• Cardiovascular Models: Heart Secondarily Affected by Disease

  2013cites this paper
• radial artery coronary bypass grafting verapamil/nitroglycerin solution, and papaverine as topical antispasmodics for Comparative efficacies and durations of action of phenoxybenzamine,

  2013cites this paper
• Expression profile of late responsive genes induced by spatial learning task: involvement of pathways in locomotion and memory

  2013cites this paper
• Cholinergic connectivity: it's implications for psychiatric disorders

  2013cites this paper
• Interaction of D3 preferring agonist (−)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264) with cloned human D2L, D2S, and D3 receptors: potent stimulation of mitogen-activated protein kinases and G protein-coupled inward rectifier potassi

  2013cites this paper
• A Gαs DREADD Mouse for Selective Modulation of cAMP Production in Striatopallidal Neurons

  2013cites this paper
• Modification of agonist binding moiety in hybrid derivative 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-1-ol/-2-amino versions: impact on functional activity and selectivity for dopamine D2/D3 receptors.

  2013cites this paper
• Receptor‐dependent regulation of dendrite formation of noradrenaline and dopamine in non‐gabaergic cerebral cortical neurons

  2013cites this paper
• Pharmacosynthetics and the Cell-Type-Specific Control of Neuronal Signaling

  2013cites this paper
• Characterization of the interaction of the dopamine D2 receptor and the cannabinoid CB1 receptor and its effects on signal transduction pathways

  2013cites this paper
• pposing effects on the phrenic motor pathway attributed to dopamine-D 1 and D 3 / D 2 receptor activation

  2012cites this paper
• Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice.

  2012cites this paper
• Challenges in understanding the impact of blood pressure management on cerebral oxygenation in the preterm brain

  2012influential citation
• Dopamine receptor antagonism disrupts social preference in zebrafish: a strain comparison study

  2012cites this paper
• Structure-activity relationship study of N⁶-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterization

  2012cites this paper
• Regenerating the brain : lessons from the Red Spotted Newt

  2012cites this paper
• UvA-DARE ( Digital Academic Repository ) Sleep bruxism : contemporary insights in diagnosis , etiology and management

  2012cites this paper
• Li+ in Bipolar Disorder – Possible Mechanisms of Its Pharmacological Mode of Action

  2012cites this paper
• Effects of ningdong granule on DA, DRD2, and HVA in a rat model of Tourette's syndrome.

  2012cites this paper
• Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

  2012cites this paper
• Inflammatory cytokines as an underlying mechanism of the comorbidity between bipolar disorder and migraine.

  2012cites this paper
• REGENERATING THE BRA IN : LESSONS FROM THE RED SPOTTED

  2012cites this paper
• An Association Study on the Polymorphisms of Dopaminergic Genes with Working Memory in a Healthy Chinese Han Population

  2012cites this paper
• Comorbidity of Migraine With ADHD

  2012cites this paper
• Prenatal Ethanol Exposure Alters Synaptic Plasticity in the Dorsolateral Striatum of Rat Offspring via Changing the Reactivity of Dopamine Receptor

  2012cites this paper
• The influence of five monoamine genes on trajectories of depressive symptoms across adolescence and young adulthood

  2012cites this paper
• Effect of duodenal levodopa infusion on blood pressure and sweating

  2012cites this paper
• A new approach for structure analysis of two‐dimensional membrane protein crystals using X‐ray powder diffraction data

  2011cites this paper
• Adult attention deficit hyperactivity disorder is associated with migraine headaches

  2011cites this paper
• A Novel Non‐phenolic Dibenzazecine Derivative with Nanomolar Affinities for Dopamine Receptors

  2011cites this paper
• Role for the Membrane Receptor Guanylyl Cyclase-C in Attention Deficiency and Hyperactive Behavior

  2011cites this paper
• Doctorate School in Molecular Medicine Doctorate Program in Genetics and Molecular Medicine Coordinator: Prof. Lucio Nitsch XXIV Cycle

  2011cites this paper
• Towards a Novel Treatment of Huntington´s Disease

  2011cites this paper
• COMPARISON OF THE SEDATIVE AND/OR ANTINOCICEPTIVE EFFECTS OF ACEPROMAZINE, LEVOMEPROMAZINE AND AZAPERONE IN HORSES / Comparação dos efeitos sedativos e/ou antinociceptivos dos tranquilizantes acepromazina, levomepromazina e azaperone em equinos.

  2011cites this paper
• Adult attention deficit hyperactivity disorder is associated with asthma

  2011cites this paper
• D2 Dopamine Receptor Mediation of Risky Decision-making

  2011cites this paper
• Are Migraine and Bipolar Disorders Comorbid Phenomena?: Findings From a Pharmacoepidemiological Study Using the Norwegian Prescription Database

  2011cites this paper
• Interaction of novel hybrid compounds with the D3 dopamine receptor: Site-directed mutagenesis and homology modeling studies.

  2011cites this paper
• Parkinson disease drug screening based on the interaction between D2 dopamine receptor and beta-arrestin 2 detected by capillary zone electrophoresis

  2011cites this paper